Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010032/S266

Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)

ABBOTT MEDICAL · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONP010032/S266

What did the FDA decide?

FDA posted a 30-day notice for PMA supplement P010032/S266, dated 2026-10-30, with decision OK30. The supplement reason is a process change involving manufacturer, sterilizer, packager, or supplier. The stated change is from an animal-derived to a non-animal-derived EBS lubricant used in TPU resin production for the BLE antenna manufacturing process.

The statement specifies that this applies to the BLE antenna used in the implantable pulse generator for either bundled device: the deep brain stimulator and the spinal cord stimulator. The device category is a totally implanted spinal-cord stimulator for pain relief, product code LGW, with Abbott Medical as the applicant. The source does not state whether the change affects device safety or performance.

FDA approval order statement

animal-derived to non-animal derived EBS [Ethylene Bis-stearamide] lubricant to be used in TPU [thermoplastic polyurethane] resin production for the BLE [Bluetooth low energy] antenna manufacturing process. This applies specifically to the BLE antenna used in the IPG [implantable pulse generator] for either bundled device; DBS [Deep Brain Stimulator] and SCS [Spinal cord Stimulator]
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Oct 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010032/S266
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
OK30
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P010032. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010032 · Original PMA

    GENESIS AND EON FAMILY NEUROSTIMULATION (IPG) SYSTEMS

  2. P010032/S261 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  3. P010032/S251 · Related supplement

    Quattrode; Octrode; Penta; Lamitrode; Tripole; TriCentrus Lead Extensions

  4. P010032/S260 · Related supplement

    Proclaim family of SCS IPG

  5. P010032/S266 received

    Application receipt date recorded by FDA.

  6. P010032/S265 · Related supplement

    Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generator

  7. P010032/S262 · Related supplement

    Spinal Cord Stimulation (SCS) External Pulse Generator (EPG)

  8. P010032/S264 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  9. P010032/S266 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P010032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010032

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Preston Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records